Screening of Neonatal UK Dried Blood Spots Using a Duplex SMN1 Screening Assay
Spinal muscular atrophy (SMA) is an autosomal inherited neuromuscular genetic disease caused, in 95% of cases, by homozygous deletions involving the <i>SMN1</i> gene exon 7. It remains the leading cause of death in children under 2 years of age. New treatments have been developed and ado...
Main Authors: | Stuart P. Adams, Emma Gravett, Natalie Kent, Susanne Kricke, Adeboye Ifederu, Mariacristina Scoto, Salma Samsuddin, Francesco Muntoni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/7/4/69 |
Similar Items
-
What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages?
by: Ines Tapken, et al.
Published: (2024-05-01) -
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds
by: Jonathan J. Cherry, et al.
Published: (2013-06-01) -
Pathological impact of SMN2 mis‐splicing in adult SMA mice
by: Kentaro Sahashi, et al.
Published: (2013-09-01) -
Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
by: Tejal Aslesh, et al.
Published: (2022-01-01) -
Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg
by: Anton Kiselev, et al.
Published: (2024-01-01)